e.g. mhealth
Search Results (1 to 10 of 85 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 28 Journal of Medical Internet Research
- 17 JMIR Research Protocols
- 14 JMIR Formative Research
- 10 JMIR Mental Health
- 5 JMIR mHealth and uHealth
- 4 JMIR Human Factors
- 1 Interactive Journal of Medical Research
- 1 JMIR Aging
- 1 JMIR Cancer
- 1 JMIR Infodemiology
- 1 JMIR Medical Informatics
- 1 JMIR Public Health and Surveillance
- 1 JMIR Serious Games
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
A study examining sleep disturbances and PTSD in survivors of wildfires revealed that approximately 49.2% (n=126) experienced symptoms of insomnia, 28.7% experienced nightmares, and 77.9% reported PTSD symptoms [12].
Studies suggest that cognitive behavioral therapy for insomnia (CBTi); cognitive behavioral therapy (CBT) for PTSD; and exposure, relaxation, and rescripting therapy (ERRT) for nightmares are effective treatments for insomnia, nightmares, and other trauma symptoms [13-18].
JMIR Hum Factors 2025;12:e65228
Download Citation: END BibTex RIS
Insomnia, characterized by the struggle to initiate or maintain sleep or the experience of nonrestorative sleep, brings along symptoms that hinder daily functioning, such as weariness, concentration difficulties, and mood disruptions [1]. Among the estimated 650,000 young adult cancer survivors (YACS, ages 18-39 years old) in the United States, up to 75% are grappling with insomnia symptoms, with nearly 30% likely to experience insomnia disorder [2-8].
JMIR Form Res 2025;9:e64869
Download Citation: END BibTex RIS
Diaphragmatic Breathing Interfaces to Promote Relaxation for Mitigating Insomnia: Pilot Study
Insomnia is an increasingly severe issue, with approximately 30% of the population experiencing related symptoms [1]. It is characterized by difficulty in falling asleep, maintaining sleep, or waking up too early and being unable to return to sleep for at least 3 nights a week. This definition is based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria. Acute insomnia lasts for 1 month, while chronic insomnia persists for over 3 months [2].
JMIR Serious Games 2025;13:e67000
Download Citation: END BibTex RIS
Studies indicate that insomnia has a high prevalence, impacting roughly 20% to 35% of the general population [10-13], and this rate is even higher among health care workers and patients with COVID-19, reaching up to 75% [8]. Substantial evidence indicates that post–COVID-19 insomnia (PCI) frequently persists over the long term [14-17], leading to serious health issues such as increased depression, prolonged work absences, and a heightened risk of hypertension [15,18,19].
JMIR Res Protoc 2025;14:e69417
Download Citation: END BibTex RIS
Then, participants read 2 vignettes and ranked mental health treatment preference options pertaining to each diagnosis presented in the vignette, with the following question: “Imagine that you have symptoms of [anxiety/insomnia] like [name of the person in the vignette] and want to seek therapy for these symptoms, please rank order the following imagining that you will be interested in seeking treatment for anxiety/insomnia at a later point.”
J Med Internet Res 2025;27:e54608
Download Citation: END BibTex RIS
Furthermore, insomnia symptoms are closely associated with SD and subthreshold anxiety, and prevention programs for subthreshold insomnia (SI) have been reported to not only decrease depressive symptoms but also improve insomnia [11]. Namely, when considering primary care for subthreshold symptoms, overlapping symptoms also need to be considered; as a result, the treatment for specific subthreshold symptoms should also have the potential to cover a wide range of subthreshold symptoms.
JMIR Form Res 2025;9:e63139
Download Citation: END BibTex RIS
The participants included both individuals with and without insomnia aged 19-70 years with the following inclusion criteria: more than 3 days a week of subjective insomnia symptoms during the past 3 months and an ISI score greater than 15 for the insomnia group, and fewer than 3 days a week of subjective insomnia symptoms during the past 3 months and an ISI score less than 8 for the no insomnia group.
JMIR Ment Health 2025;12:e67478
Download Citation: END BibTex RIS
Chronic insomnia is a major global health concern owing to its high prevalence and its negative impact on mental and physical health [1,2]. The usual approach to treat chronic insomnia includes the prescription of medication, such as nonbenzodiazepine hypnotics [3-5]. Nonpharmacological approaches, such as cognitive behavioral therapy for insomnia (CBT-I), whose goal is to restructure a person’s sleeping behavior, is an evidence-based psychotherapy that has been shown to treat this condition effectively.
JMIR Ment Health 2025;12:e51022
Download Citation: END BibTex RIS
Insomnia is a condition characterized by self-reported difficulty in falling asleep or staying asleep, with accompanying distress or impairment [1]. Insomnia symptoms can be chronic or acute [2]. Approximately 10%-30% of the population is estimated to experience either chronic or acute insomnia, with insomnia more common among women and older adults [3,4]. One prospective cohort study reported an insomnia incidence of 13.9%—of those, 37.5% developed chronic insomnia over a 5-year period [5].
J Med Internet Res 2025;27:e58902
Download Citation: END BibTex RIS
An 11-year analysis by the US Veterans Health Administration identified sleep apnea and insomnia as the most common sleep disorders, at 47% and 26%, respectively [11]. Nearly 1 billion people worldwide experience from sleep apnea, with 430 million experiencing moderate to severe cases [12]. Prevalence increases with age, male gender, and higher BMI [13].
J Med Internet Res 2024;26:e51615
Download Citation: END BibTex RIS